Replies to post #191939 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Pretty sure Anavex will receive the tax incentive refund on all their clinical activities in AU.

[Doc328]

My understanding is that small companies are eligible to receive the incentives of 43.5% of R and D money spent in Australia refunded in cash. Therefore they should be able to do the 2 additional sites for less money than another EU country (similar initial spend followed by 43% refund).

[sokol]

Yes, screening and selecting the patients for the AD trial is critical. However, over 20% of the 450 patients — around 100 patients — have been enrolled. Remember too that the PDD trial is a dementia trial. 70% enrollment in the PDD trial is achieved. If we receive positive news from the PDD trial, we should be attracting partners for Alzheimer’s and Parkinson's.
If we receive negative dementia results in the PDD trial, that will be a set back indeed, but I suppose it is possible that Anavex may still redeem itself with the larger number and more carefully selected patients in the AD trial.